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 ABSTRACT 
Synbiotics approach complementarily and synergistically toward the balance of 
gastrointestinal microbiota and improvement in bowel functions. A randomised, double-
blind, placebo-controlled study was conducted to examine the effects of a synbiotics 
supplement among constipated adults. A total of 85 constipated adults, diagnosed by Rome 
III criteria for functional constipation were randomised to receive either synbiotics (n = 43) or 
placebo (n = 42) once daily (2.5 g) in the morning for 12 weeks. Eight times of follow-up 
was conducted every fortnightly with treatment response based on a questionnaire that 
included a record of evacuation (stool frequency, stool type according to Bristol Stool Form 
Scale), Patients Assessment on Constipation Symptoms (PAC-SYM), and Patients 
Assessment on Constipation Quality of Life (PAC-QOL). There were no significant 
differences in stool evacuation, but defecation frequency and stool type in treatment group 
were improved tremendously than in placebo group. While the treatment group was reported 
to have higher reduction in severity of functional constipation symptoms, the differences 
were not statistically significant. Dietary supplementation of synbiotics in this study 
suggested that the combination of probiotics and prebiotics improved the functional 
constipation symptoms and quality of life although not significant. This was due to the high 
placebo effect which synbiotics failed to demonstrate benefit over the controls. 
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